Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China
China has the highest number of hepatitis B and C cases globally. Despite remarkable achievements, China faces daunting challenges in achieving international targets for hepatitis elimination. As part of a large-scale project assessing China’s progress in achieving health-related Sustainable Develop...
Saved in:
| Main Authors: | Shenglan Tang, Wenhui Mao, Shu Chen, Lei Guo, Jiahui Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-06-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/5/6/e002306.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment Options for Hepatitis B
by: JM Conly, et al.
Published: (2007-01-01) -
Financing the introduction of new vaccines to the national immunisation programme in China: challenges and options for action
by: Shenglan Tang, et al.
Published: (2025-03-01) -
Trends of breastfeeding indicators in Brazil from 1996 to 2019 and the gaps to achieve the WHO/UNICEF 2030 targets
by: Gilberto Kac, et al.
Published: (2023-09-01) -
Beyond 2030: structures for achieving sustainable development
by: Tom Cernev, et al.
Published: (2024-10-01) -
Status of hepatitis B virus and hepatitis C elimination in Singapore: a call for action
by: Yu Jun Wong, et al.
Published: (2025-07-01)